MGMT and central nervous system cancer: A more recent review from 2022 showed that gliomas with methylated MGMT promoter are typically found in the temporal lobe of the left hemisphere and display ring contrast-enhancement, more central necrosis, higher minimum apparent diffusion coefficient, and higher relative cerebral blood flow [9].